Abstract
A highly crystallizable T4 lysozyme (T4L) was fused to the N-terminus of the β(2) adrenergic receptor (β(2)AR), a G-protein coupled receptor (GPCR) for catecholamines. We demonstrate that the N-terminal fused T4L is sufficiently rigid relative to the receptor to facilitate crystallogenesis without thermostabilizing mutations or the use of a stabilizing antibody, G protein, or protein fused to the 3rd intracellular loop. This approach adds to the protein engineering strategies that enable crystallographic studies of GPCRs alone or in complex with a signaling partner.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amino Acid Sequence
-
Animals
-
Bacteriophage T4 / enzymology*
-
Binding Sites
-
Binding, Competitive
-
Crystallization
-
Crystallography, X-Ray
-
Dihydroalprenolol / chemistry
-
Dihydroalprenolol / metabolism
-
Humans
-
Models, Molecular
-
Molecular Sequence Data
-
Muramidase / chemistry*
-
Muramidase / genetics
-
Muramidase / metabolism
-
Mutation
-
Protein Binding
-
Protein Conformation
-
Protein Engineering / methods
-
Protein Structure, Secondary
-
Protein Structure, Tertiary
-
Receptors, Adrenergic, beta-2 / chemistry*
-
Receptors, Adrenergic, beta-2 / genetics
-
Receptors, Adrenergic, beta-2 / metabolism
-
Receptors, G-Protein-Coupled / chemistry*
-
Receptors, G-Protein-Coupled / genetics
-
Receptors, G-Protein-Coupled / metabolism
-
Recombinant Fusion Proteins / chemistry
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / metabolism
-
Sf9 Cells
-
Tritium
-
Viral Proteins / chemistry*
-
Viral Proteins / genetics
-
Viral Proteins / metabolism
Substances
-
Receptors, Adrenergic, beta-2
-
Receptors, G-Protein-Coupled
-
Recombinant Fusion Proteins
-
Viral Proteins
-
Tritium
-
Dihydroalprenolol
-
Muramidase